Abstract

Recently, we have experienced a serious pandemic. Despite significant technological advances in molecular technologies, it is very challenging to slow down the infection spread. It appeared that due to globalization, SARS-CoV-2 spread easily and adapted to new environments or geographical or weather zones. Additionally, new variants are emerging that show different infection potential and clinical outcomes. On the other hand, we have some experience with other pandemics and some solutions in virus elimination that could be adapted. This is of high importance since, as the latest reports demonstrate, vaccine technology might not follow the new, mutated virus outbreaks. Thus, identification of novel strategies and markers or diagnostic methods is highly necessary. For this reason, we present some of the latest views on SARS-CoV-2/COVID-19 therapeutic strategies and raise a solution based on miRNA. We believe that in the face of the rapidly increasing global situation and based on analogical studies of other viruses, the possibility of using the biological potential of miRNA technology is very promising. It could be used as a promising diagnostic and prognostic factor, as well as a therapeutic target and tool.

MeSH

Solutions, Infections, Morbidity, Therapeutics, Technology, Viruses, Coronavirus, Sars Virus, Micrornas, Pandemics, Covid-19, Sars-Cov-2

Cited by

• Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19. J Pharmacol Exp Ther, 2022
• Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Mol Biomed, 2022
• miR-146a, miR-221, and miR-155 are Involved in Inflammatory Immune Response in Severe COVID-19 Patients. Diagnostics (Basel), 2023
• MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review. J Infect Public Health, 2022
• Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery. Int J Mol Sci, 2023
• miRNA expression in COVID-19. Gene Rep, 2022
• microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review. Life (Basel), 2022
• Serum microRNAs targeting and genes distinguish asymptomatic from critical COVID-19 patients. Mol Ther Nucleic Acids, 2022
• Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol, 2022
• Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. J Pers Med, 2022
• microRNA, the Innate-Immune System and SARS-CoV-2. Front Cell Infect Microbiol, 2022
• Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg Microbes Infect, 2022
• Metabolic, fibrotic and splicing pathways are all altered in Emery-Dreifuss muscular dystrophy spectrum patients to differing degrees. Hum Mol Genet, 2023